Ivim Health reports on the effectiveness of GLP-1 pills vs. Ozempic, emphasizing personalized care for obesity management.

Ozempic (semaglutide) and Mounjaro (tirzepatide) are injectable type 2 diabetes medications prescribed to lower blood sugar, ...

Doctronic reports new AI analysis reveals GLP-1 medications may cause underreported symptoms like menstrual irregularities ...

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with type 2 diabetes.

The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral semaglutide version.

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose some weight. Reading time 5 minutes The arrival of semaglutide and similar ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss — when a ...

The MarketWatch News Department was not involved in the creation of this content. -- Ozempic(R) is indicated as an adjunct to diet, exercise, and standard of care to reduce the risk of major adverse ...